The accompanying notes are
an integral part of the unaudited condensed financial statements.
The accompanying notes are
an integral part of the unaudited condensed financial statements.
The accompanying notes are an
integral part of the unaudited condensed financial statements.
The accompanying notes are an
integral part of the unaudited condensed financial statements.
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 1 - ORGANIZATION AND BUSINESS BACKGROUND
Venus Acquisition Corporation
(the “Company”) is a blank check company incorporated in the Cayman Islands on May 14, 2018. The Company was formed for the
purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with
one or more businesses (“Business Combination”).
On June 10, 2021, the Company,
VIYI Algorithm Inc., a Cayman Islands exempted company (“Viyi”), Venus Merger Sub Corp., a Cayman Islands exempted company
and wholly-owned subsidiary of the Company (the “Merger Sub”) and WiMi Hologram Cloud Inc., a Cayman Islands company and the
legal and beneficial owner of a majority of the issued and outstanding voting securities of Viyi (“Majority Shareholder”),
entered into a Merger Agreement (the "Merger Agreement"). Venus Merger Sub Corp. is a company incorporated in the Cayman Islands
for the purpose of effecting the Business Combination and to serve as the vehicle for, and be subsumed by, VIYI Algorithm Inc., pursuant
to the terms of the Merger Agreement Merger Sub is wholly owned by Venus. See the further description below regarding the proposed Business
combination with Viyi.
The Company is an early stage
and an emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth
companies.
All activity through September
30, 2021 relates to the Company’s formation, completion of its initial public offering (the “Initial Public Offering”)
which occurred on February 11, 2021 and negotiation and consummation of the proposed Business Combination with Viyi. The Company will
not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering, which proceeds are held in trust.
Financing
The registration statement
for the Company’s Initial Public Offering became effective on February 8, 2021. On February 11, 2021, the Company consummated the
Initial Public Offering of 4,600,000 units (the “Public Units”), which includes the full exercise by the underwriter of its
over-allotment option in the amount of 600,000 Public Units, at $10.00 per Public Unit, generating gross proceeds of $46,000,000 which
is described in Note 4.
Simultaneously with the closing
of the Initial Public Offering, the Company consummated the sale of, 225,000 units (the “Private Placement Units”) at a price
of $10.00 per Private Placement Unit in a private placement to Yolanda Management Corporation (the “Sponsor”), generating
gross proceeds of $2,250,000, which is described in Note 5.
Transaction costs amounted
to $2,462,765, consisting of $805,000 of underwriting fees, $1,150,000 of deferred underwriting fees and $507,765 of other offering costs.
Trust account
Following the closing of
the Initial Public Offering on February 11, 2021, the aggregate amount of $46,460,000 ($10.10 per Public Unit) was placed in a trust account
(the “Trust account”) with Wilmington Trust, National Association acting as trustee. The funds held in the Trust account can
be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity
of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund meeting certain conditions of
Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination
and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below, except that interest
earned on the Trust Account can be released to the Company to pay its tax obligations. At closing of the Initial Public Offering, the
sum of $418,430 was released to the Company to fund its working capital needs.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Business Combination
The Company’s management
has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and sale of the Private
Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.
NASDAQ rules provide that the Business Combination must be with one or more target businesses that together have a fair market value equal
to at least 80% of the balance in the Trust Account (as defined below) (less any deferred underwriting commissions and taxes payable on
interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a Business
Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or
otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under
the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will
be able to successfully effect a Business Combination.
The Company will provide
its shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination
either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In
connection with an Initial Business Combination, the Company may seek shareholder approval of a Business Combination at a meeting called
for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination.
The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation
of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor
of the Business Combination.
Notwithstanding the foregoing,
if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules,
the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any
affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined
under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from seeking
redemption rights with respect to 15% or more of the Public Shares without the Company’s prior written consent.
If a shareholder vote is
not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant
to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender offer rules of the Securities
and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be
included in a proxy statement with the SEC prior to completing a Business Combination.
The shareholders will be
entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per Public Share,
subject to increase of up to an additional $0.30 per Public Share in the event that the Sponsor elects to extend the period of time to
consummate a Business Combination (see below), plus any pro rata interest earned on the funds held in the Trust Account and not previously
released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders who redeem their Public Shares
will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as discussed in Note 10). There
will be no redemption rights upon the completion of a Business Combination with respect to the Company’s rights or warrants. The
ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering,
in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The Sponsor and any of the
Company’s officers or directors that may hold Founder Shares (as defined in Note 6) (the “shareholders”) and the underwriters
will agree (a) to vote their Founder Shares, the ordinary shares included in the Private Units (the “Private Shares”) and
any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination, (b) not to propose an amendment
to the Company’s Amended and Restated Memorandum and Articles of Association with respect to the Company’s pre-Business Combination
activities prior to the consummation of a Business Combination unless the Company provides dissenting public shareholders with the opportunity
to redeem their Public Shares in conjunction with any such amendment; (c) not to redeem any shares (including the Founder Shares) and
Private Shares into the right to receive cash from the Trust Account in connection with a shareholder vote to approve a Business Combination
(or to sell any shares in a tender offer in connection with a Business Combination if the Company does not seek shareholder approval in
connection therewith) or a vote to amend the provisions of the Amended and Restated Memorandum and Articles of Association relating to
shareholders’ rights of pre-Business Combination activity and (d) that the Founder Shares and Private Shares shall not participate
in any liquidating distributions upon winding up if a Business Combination is not consummated. However, the shareholders will be entitled
to liquidating distributions from the Trust Account with respect to any Public Shares purchased during or after the Initial Public Offering
if the Company fails to complete its Business Combination.
On June 10, 2021, the Company
entered into a merger agreement (the “Merger Agreement”), which provides for a Business Combination between Venus and VIYI
Algorithm Inc. Pursuant to the Merger Agreement, the Business Combination will be effected as a stock transaction and is intended to be
qualified as a tax-free reorganization. The Merger Agreement is by and among Venus, Merger Sub, VIYI, and WiMi Hologram Cloud Inc, a Cayman
Islands limited liability company as the representative of VIYI’s stockholders. The aggregate consideration for the Acquisition
Merger is $400,000,000, payable in the form of 39,600,000 newly issued shares of common stock of Merger Sub (“Merger Sub Common
Stock”) valued at $10.10 per share.
Upon the closing of the Business
Combination, the former Venus shareholders will receive the consideration specified below and the former VIYI stockholders will receive
an aggregate of 39,600,000 shares of Merger Sub Common Stock.
The Company will have until
February 11, 2022 to consummate a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business
Combination within 12 months, the Company may extend the period of time to consummate a Business Combination up to nine times, each by
an additional month (for a total of 21 months to complete a Business Combination (the “Combination Period”). In order to extend
the time available for the Company to consummate a Business Combination, the Sponsor or its affiliate or designees must deposit into the
Trust Account $153,333 (approximately $0.033 per Public Share), up to an aggregate of $1,380,000, or $0.30 per Public Share, on or prior
to the date of the applicable deadline, for each one month extension. Any funds which may be provided to extend the time frame will be
in the form of a loan to us from our sponsor. The terms of any such loan have not been definitely negotiated, provided, however, any loan
will be interest free and will be repayable only if we compete a business combination.
The Company will be seeking
approval from its shareholders of the proposed Business Combination and Merger with VIYI. The Company has filed a Form S-4/Proxy Statement
with the SEC regarding the terms and conditions of the proposed Merger with Viyi and other matters. The Form S-4/Proxy Statement is under
review by the SEC. Assuming that the S-4/Proxy Statement is declared effective by the SEC, of which there can be no assurance, the Company
will provide its shareholders with definitive materials to consider in connection with the solicitation for approval of the Merger with
Viyi and other matters as described in the S-4/Proxy Statement.
The Company will have until
February 11, 2022 to consummate a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business
Combination within 12 months (including the proposed Business combination with Viyi), the Company may extend the period of time to consummate
a Business Combination up to nine times, each by an additional month (for a total of 21 months to complete a Business Combination (the
“Combination Period”). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor
or its affiliate or designees must deposit into the Trust Account $153,333 (approximately $0.033 per Public Share), up to an aggregate
of $1,380,000, or $0.30 per Public Share, on or prior to the date of the applicable deadline, for each one month extension. Any funds
which may be provided to extend the time frame will be in the form of a loan to us from our sponsor. The terms of any such loan have not
been definitely negotiated, provided, however, any loan will be interest free and will be repayable only if we compete a business combination.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
If the Company is unable
to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of
winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of the outstanding Public
Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest
earned (net of taxes payable and less interest to pay dissolution expenses up to $50,000), divided by the number of then outstanding Public
Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive
further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the remaining shareholders and the Company’s board of directors, proceed to commence a voluntary liquidation
and thereby a formal dissolution of the Company, subject in each case to its obligations to provide for claims of creditors and the requirements
of applicable law. The underwriter has agreed to waive its rights to the deferred underwriting commission held in the Trust Account in
the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be
included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of
such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial
Public Offering price per Unit ($10.00).
The Sponsor has agreed that
it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products sold to the Company, or
a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust
Account to below (i) $10.10 per share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation
of the Trust Account due to reductions in the value of the trust assets, except as to any claims by a third party who executed a waiver
of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters
of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities
Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible
to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have
to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers, prospective target businesses
or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim
of any kind in or to monies held in the Trust Account.
NOTE 2 –
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
On April 12, 2021, the Acting Director of the
Division of Corporation Finance and Acting Chief Accountant of the SEC together issued a statement regarding the accounting and reporting
considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting
Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”).
Specifically, the SEC Statement focused on certain provisions that provided for potential changes to the settlement amounts dependent
upon the characteristics of the holder of the warrant, which terms are similar to those contained in the warrant agreement governing the
Company’s warrants.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The Company’s management evaluated the warrants
under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section
815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and
states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s
common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require
an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. The Company’s
Private Warrants are not indexed to the Company’s common shares in the manner contemplated by ASC Section 815-40-15 because the
holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, the tender offer
provision included in the warrant agreement fails the “classified in shareholders’ equity” criteria as contemplated
by ASC Section 815-40-25. Management of the Company and the Audit Committee of the Board of Directors, following discussion with its independent
auditors, have determined that only the Private Warrants should be classified as liabilities and the Public Warrants should be classified
as equity. The Company previously accounted for the Public Warrants as components of liabilities.
In further consideration of the guidance in Accounting
Standards Codification (“ASC”) 815-40, Derivatives and Hedging — Contracts in Entity’s Own Equity (“ASC
815”), the Company concluded that a provision in the warrant agreement related to certain transfer provisions precludes the Private
Warrants from being accounted for as components of equity. As the Private Warrants meet the definition of a derivative as contemplated
in ASC 815, the Private Warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at inception
(on the date of the Initial Public Offering) and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes
in fair value recognized in the Statements of Operations in the period of change.
In addition, the Company concluded it should restate
its financial statements to classify all ordinary shares subject to possible redemption in temporary equity. In accordance
with the SEC and its staff’s guidance on redeemable equity instruments, ASC Topic 480, Distinguishing Liabilities from Equity
(ASC 480), paragraph 10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject to redemption
to be classified outside of permanent equity. The Company had previously classified a substantial portion of its ordinary shares in permanent
equity. Although the Company did not specify a maximum redemption threshold, its charter provides that the Company will not redeem its
public shares in an amount that would cause its net tangible assets to be less than $5,000,001. The Company considered that the threshold
would not change the nature of the underlying shares as redeemable and thus would be required to be disclosed outside equity. As a result,
the Company restated its previously filed financial statements to classify all ordinary shares as temporary equity and to recognize accretion
from the initial book value to redemption value at the time of its Initial Public Offering and in accordance with ASC 480. The change
in the carrying value of redeemable shares of ordinary shares resulted in charges against additional paid-in capital and accumulated deficit.
In accordance with SEC Staff Accounting Bulletin
No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements
when Quantifying Misstatements in Current Year Financial Statements;” the Company evaluated the changes and has determined that
the related impacts were material to any previously presented financial statements. Therefore, the Company, in consultation with its Audit
Committee, concluded that its previously issued financial statements impacted should be restated to report all public shares as temporary
equity.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The impact to the previously presented financial
statements is presented below:
Adjustment #1 refer to Public warrant reclassify
from warrant liabilities to equity component.
Adjustment #2 refer to classify all public shares
as temporary equity.
REVISION OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As
|
|
|
|
|
|
|
|
|
|
|
|
|
Previously
|
|
|
|
|
|
|
|
|
As
|
|
|
|
Reported
|
|
|
Adjustments #1
|
|
|
Adjustments #2
|
|
|
Restated
|
|
Balance sheet as of February 11, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities
|
|
|
6,420,000
|
|
|
|
(6,040,000
|
)
|
|
|
-
|
|
|
|
380,000
|
|
Total liabilities
|
|
|
7,808,428
|
|
|
|
(6,040,000
|
)
|
|
|
-
|
|
|
|
1,768,428
|
|
Ordinary shares subject to possible redemption
|
|
|
34,281,198
|
|
|
|
-
|
|
|
|
12,178,802
|
|
|
|
46,460,000
|
|
Ordinary shares
|
|
|
2,656
|
|
|
|
-
|
|
|
|
(1,206
|
)
|
|
|
1,450
|
|
Additional paid-in capital
|
|
|
5,108,455
|
|
|
|
6,040,000
|
|
|
|
(11,148,455
|
)
|
|
|
-
|
|
Accumulated deficit
|
|
|
(111,103
|
)
|
|
|
-
|
|
|
|
(1,029,141
|
)
|
|
|
(1,140,244
|
)
|
Total shareholders’ equity (deficit)
|
|
|
5,000,008
|
|
|
|
6,040,000
|
|
|
|
(12,178,802
|
)
|
|
|
(1,138,794
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet as of March 31, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities
|
|
|
6,450,000
|
|
|
|
(6,060,000
|
)
|
|
|
-
|
|
|
|
390,000
|
|
Total liabilities
|
|
|
7,617,136
|
|
|
|
(6,060,000
|
)
|
|
|
-
|
|
|
|
1,557,136
|
|
Ordinary shares subject to possible redemption
|
|
|
34,155,320
|
|
|
|
-
|
|
|
|
12,304,680
|
|
|
|
46,460,000
|
|
Ordinary shares
|
|
|
2,668
|
|
|
|
-
|
|
|
|
(1,218
|
)
|
|
|
1,450
|
|
Additional paid-in capital
|
|
|
5,234,320
|
|
|
|
6,040,000
|
|
|
|
(11,274,320
|
)
|
|
|
-
|
|
Accumulated deficit
|
|
|
(236,985
|
)
|
|
|
20,000
|
|
|
|
(1,029,142
|
)
|
|
|
(1,246,127
|
)
|
Total shareholders’ equity (deficit)
|
|
|
5,000,003
|
|
|
|
6,060,000
|
|
|
|
(12,304,680
|
)
|
|
|
(1,244,677
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of operations for the three months ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in fair value of warrant liabilities
|
|
|
(30,000
|
)
|
|
|
20,000
|
|
|
|
-
|
|
|
|
(10,000
|
)
|
Net Loss
|
|
|
(108,323
|
)
|
|
|
20,000
|
|
|
|
-
|
|
|
|
(88,323
|
)
|
Basic and diluted weighted average shares outstanding, ordinary stock subject to possible redemption
|
|
|
-
|
|
|
|
-
|
|
|
|
2,453,333
|
|
|
|
2,453,333
|
|
Basic and diluted income per share, ordinary share subject to possible redemption
|
|
|
-
|
|
|
|
-
|
|
|
|
0.49
|
|
|
|
0.49
|
|
Basic and diluted weighted average shares outstanding, Non-redeemable ordinary shares
|
|
|
3,073,566
|
|
|
|
-
|
|
|
|
(1,763,566
|
)
|
|
|
1,310,000
|
|
Basic and diluted net loss per share, non-redeemable ordinary shares
|
|
|
(0.03
|
)
|
|
|
-
|
|
|
|
(0.96
|
)
|
|
|
(0.99
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of changes in shareholders’ deficit for the three months ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial classification of shares subject to conversion – ordinary shares – no. of shares
|
|
|
(3,394,178
|
)
|
|
|
-
|
|
|
|
(1,205,822
|
)
|
|
|
(4,600,000
|
)
|
Initial classification of shares subject to conversion – ordinary shares – amount
|
|
|
(3,394
|
)
|
|
|
-
|
|
|
|
(1,206
|
)
|
|
|
(4,600
|
)
|
Initial classification of shares subject to conversion – additional paid-in capital
|
|
|
(34,277,804
|
)
|
|
|
-
|
|
|
|
(10,967,390
|
)
|
|
|
(45,245,194
|
)
|
Initial classification of shares subject to conversion – total shareholder’s deficit
|
|
|
(34,281,198
|
)
|
|
|
-
|
|
|
|
(10,968,596
|
)
|
|
|
(45,249,794
|
)
|
Allocation of offering costs to common stock subject to redemption
|
|
|
-
|
|
|
|
-
|
|
|
|
2,422,602
|
|
|
|
2,422,602
|
|
Accretion of carrying value to redemption value
|
|
|
-
|
|
|
|
-
|
|
|
|
(2,603,666
|
)
|
|
|
(2,603,666
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of cash flows for the three months ended March 31, 2021 (unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(108,323
|
)
|
|
|
20,000
|
|
|
|
-
|
|
|
|
(88,323
|
)
|
Change in fair value of warrant liabilities
|
|
|
30,000
|
|
|
|
(20,000
|
)
|
|
|
-
|
|
|
|
10,000
|
|
Initial classification of shares subject to conversion
|
|
|
(34,281,198
|
)
|
|
|
-
|
|
|
|
(10,968,596
|
)
|
|
|
(45,249,794
|
)
|
Change in value of shares subject to conversion
|
|
|
125,878
|
|
|
|
-
|
|
|
|
(125,878
|
)
|
|
|
-
|
|
Allocation of offering costs to common stock subject to redemption
|
|
|
-
|
|
|
|
-
|
|
|
|
2,422,602
|
|
|
|
2,422,602
|
|
Accretion of carrying value to redemption value
|
|
|
-
|
|
|
|
-
|
|
|
|
(2,603,666
|
)
|
|
|
(2,603,666
|
)
|
Notes 3, 5, 8 and 9 have been updated to reflect the restatements.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE
3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (AS RESTATED)
Basis of presentation
The accompanying financial
statements are presented in U.S. Dollars and conformity with accounting principles generally accepted in the United States of America
(“GAAP”) and pursuant to the rules and regulations of the SEC. The interim financial information provided is unaudited, but
includes all adjustments which management considers necessary for the fair presentation of the results for these periods. Operating results
for the interim period ended March 31, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending
December 31, 2021. The information included in this Form 10-Q/A should be read in conjunction with Management’s Discussion and Analysis,
and the financial statements and notes thereto included in the Company’s Form S-1 for the fiscal year ended December 31, 2020, filed
with the SEC on March 29, 2021.
Emerging Growth Company
The Company is an “emerging
growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012
(the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable
to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the
auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation
in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1)
of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of financial
statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period.
Making estimates requires
management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly
from those estimates.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Cash
The Company considers all
short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have
any cash equivalents as of March 31, 2021 and December 31, 2020.
Cash and Investments Held
in Trust Account
At March 31, 2021, the assets
held in the Trust Account are held in US Treasury securities.
The Company classifies its
U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments — Debt and Equity
Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity.
Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheet and adjusted for the amortization
or accretion of premiums or discounts.
Warrants
The Company accounts for
warrants (Public Warrants or Private Warrants) as either equity-classified or liability-classified instruments based on an assessment
of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”)
Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815,
Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for
equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether
the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control,
among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the
time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants
that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time
of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to
be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the
estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations. The Company has elected
to account for its Public Warrants as equity and the Private Warrants as liabilities.
Ordinary Shares Subject to
Possible Redemption
The Company accounts for
its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary share subject to mandatory redemption
(if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of
uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares
are classified as shareholders’ equity. As of March 31, 2021, the Company’s ordinary shares feature certain redemption rights
that are considered to be outside of the Company’s control. 4,600,000 ordinary shares subject to possible redemption are presented
as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Offering Costs
The Company complies with
the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A – “Expenses of
Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date
that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the Public Offering.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Fair Value of Financial Instruments
FASB ASC Topic 820 “Fair
Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures
about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly
transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with
the market approach, income approach and cost approach shall be used to measure fair value. FASB ASC Topic 820 establishes a fair value
hierarchy for inputs, which represent the assumptions used by the buyer and seller in pricing the asset or liability. These inputs are
further defined as observable and unobservable inputs. Observable inputs are those that buyer and seller would use in pricing the asset
or liability based on market data obtained from sources independent of the Company. Unobservable inputs reflect the Company’s assumptions
about the inputs that the buyer and seller would use in pricing the asset or liability developed based on the best information available
in the circumstances.
The fair value hierarchy
is categorized into three levels based on the inputs as follows:
Level 1 —
Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to
access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily
and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.
Level 2 —
Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not
active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived
principally from or corroborated by market through correlation or other means.
Level 3 —
Valuations based on inputs that are unobservable and significant to the overall fair value measurement.
The fair value of the Company’s
certain assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,”
approximates the carrying amounts represented in the balance sheet. The fair values of cash and cash equivalents, and other current assets,
accrued expenses, due to sponsor are estimated to approximate the carrying values as of March 31, 2021 due to the short maturities of
such instruments.
Concentration of Credit Risk
Financial instruments that
potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has
not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Income Taxes
The Company complies with
the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach
to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between
the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted
tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are
established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
ASC Topic 740 prescribes
a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or
expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained
upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only
major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits, if any, as income
tax expense. There were no unrecognized tax benefits as of March 31, 2021 and December 31, 2020 and no amounts accrued for interest and
penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material
deviation from its position.
The Company may be subject
to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations may include questioning
the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with foreign tax laws. The Company’s
management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
The Company is considered
to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes
or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for
the periods presented.
Net Loss Per Share (As Restated)
The Company calculates net loss
per share in accordance with ASC Topic 260, Earnings per Share. In order to determine the net income (loss) attributable to both the redeemable
shares and non-redeemable shares, the Company first considered the undistributed income (loss) allocable to both the redeemable ordinary
shares and non-redeemable ordinary shares and the undistributed income (loss) is calculated using the total net loss less any dividends
paid. The Company then allocated the undistributed income (loss) ratably based on the weighted average number of shares outstanding between
the redeemable and non-redeemable ordinary shares. Any remeasurement of the accretion to redemption value of the ordinary shares subject
to possible redemption was considered to be dividends paid to the public stockholders. As of March 31, 2021, the Company has not considered
the effect of the warrants sold in the Initial Public Offering to purchase an aggregate of 2,412,500 shares in the calculation of diluted
net loss per share, since the exercise of the warrants is contingent upon the occurrence of future events and the inclusion of such warrants
would be anti-dilutive and the Company did not have any other dilutive securities and other contracts that could, potentially, be exercised
or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic
loss per share for the period presented.
The net loss per share presented in the unaudited condensed statement
of operations is based on the following:
Net loss per share presented in the unaudited condensed
statement of operation
|
|
|
|
|
|
|
|
|
For the Three Months Ended
March 31,
2021
|
|
|
For the Three Months Ended
March 31,
2020
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(88,323
|
)
|
|
$
|
(7,355
|
)
|
Accretion of carrying value to redemption value
|
|
|
(3,632,808
|
)
|
|
|
-
|
|
Net profit
|
|
$
|
(3,721,131
|
)
|
|
$
|
(7,355
|
)
|
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Basic And Diluted Net Loss Per Share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended
March 31, 2021
|
|
|
For the Three Months Ended
March 31, 2020
|
|
|
|
Redeemable Ordinary shares
|
|
|
Non-Redeemable Ordinary shares
|
|
|
Redeemable Ordinary shares
|
|
|
Non-Redeemable Ordinary shares
|
|
Basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerators:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allocation of net loss including carrying value to redemption value
|
|
$
|
(2,425,821
|
)
|
|
$
|
(1,295,310
|
)
|
|
$
|
-
|
|
|
$
|
(7,355
|
)
|
Accretion of carrying value to redemption value
|
|
|
3,632,808
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Allocation of net income (loss)
|
|
$
|
1,206,987
|
|
|
$
|
(1,295,310
|
)
|
|
$
|
-
|
|
|
$
|
(7,355
|
)
|
Denominators:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding
|
|
|
2,453,333
|
|
|
|
1,310,000
|
|
|
|
-
|
|
|
|
1,150,000
|
|
Basic and diluted net income (loss) per share
|
|
$
|
0.49
|
|
|
$
|
(0.99
|
)
|
|
$
|
-
|
|
|
$
|
(0.01
|
)
|
Recently Issued Accounting
Standards
Management does not believe
that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the
Company’s financial statements.
NOTE 4 — CASH AND INVESTMENT
HELD IN TRUST ACCOUNT
As of March 31, 2021, investment
securities in the Company’s Trust Account consisted of $46,460,382 in United States Treasury Bills and $0 in cash. The Company classifies
its United States Treasury securities as available-for-sale. Available-for-sale marketable securities are recorded at their estimated
fair value on the accompanying March 31, 2021 balance sheet. The carrying value, including gross unrealized holding gain as other comprehensive
income and fair value of held to marketable securities on March 31, 2021 are as follows:
Schedule of carrying value, including gross unrealized holding gain as other comprehensive income and fair value of held to marketable
securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Value
|
|
|
|
|
|
Fair Value
|
|
|
|
as of March 31,
|
|
|
Gross
|
|
|
as of March 31,
|
|
|
|
2021
|
|
|
Unrealized
|
|
|
2021
|
|
|
|
(unaudited)
|
|
|
Holding Gain
|
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Available-for-sale marketable securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury Securities
|
|
$
|
46,460,382
|
|
|
$
|
—
|
|
|
$
|
46,460,382
|
|
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 5 – INITIAL PUBLIC OFFERING (AS RESTATED)
On February 11, 2021, the
Company sold 4,600,000 Units which includes a full exercise by the underwriters of their over-allotment option in the amount of 600,000
Public Units, at a purchase price of $10.00 per Unit. Each Unit will consist of one ordinary share, one right (“Public Right”)
and one redeemable warrant (“Public Warrant”). Each Public Right will convert into one-tenth (1/10) of one ordinary share.
Each Public Warrant will entitle the holder to purchase one-half of one ordinary share at an exercise price of $11.50 per whole share
(see Note 8).
If the Company does not complete
its Business Combination within the necessary time period described in Note 1, the Public Rights will expire and be worthless. Since the
Company is not required to net cash settle the Rights and the Rights are convertible upon the consummation of an initial Business Combination,
the Management determined that the Rights are classified within shareholders’ equity as “Additional paid-in capital”
upon their issuance in accordance with ASC 815-40. The proceeds from the sale are allocated to Public Shares and Rights based on the relative
fair value of the securities in accordance with ASC 470-20-30. The value of the Public Shares and Rights will be based on the closing
price paid by investors.
All of the 4,600,000 public shares sold as part
of the Public Units in the Initial Public Offering contain a redemption feature which allows for the redemption of such public shares
if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to
the Company’s amended and restated memorandum and articles of association, or in connection with the Company’s liquidation.
In accordance with the Securities and Exchange Commission (the “SEC”) and its staff’s guidance on redeemable equity
instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary
shares subject to redemption to be classified outside of permanent equity.
The Company’s redeemable ordinary shares
is subject to SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99. If it is
probable that the equity instrument will become redeemable, the Company has the option to either accrete changes in the redemption value
over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later)
to the earliest redemption date of the instrument or to recognize changes in the redemption value immediately as they occur and adjust
the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize
the changes immediately. The accretion or remeasurement is treated as a deemed dividend (i.e., a reduction to retained earnings, or in
absence of retained earnings, additional paid-in capital).
As of March 31, 2021, the ordinary shares reflected
on the balance sheet are reconciled in the following table.
Schedule of reconcilation
|
|
|
|
|
|
|
March 31,
|
|
|
|
2021
|
|
Gross proceeds
|
|
$
|
46,000,000
|
|
Less:
|
|
|
|
|
Proceeds allocated Public Warrants
|
|
|
(647,162
|
)
|
Proceeds allocated Public Rights
|
|
|
(103,044
|
)
|
Offering costs of Public Shares
|
|
|
(2,422,602
|
)
|
Plus:
|
|
|
|
|
Accretion of carrying value to redemption value
|
|
|
3,632,808
|
|
Common stock subject to possible redemption
|
|
$
|
46,460,000
|
|
The Company paid an upfront
underwriting discount of $805,000 (1.75%) of the per unit offering price to the underwriter at the closing of the Public Offering, with
an additional fee of $1,150,000 (the “Deferred Discount”) of 2.5% of the gross offering proceeds payable upon the Company’s
completion of the Business Combination. The Deferred Discount will become payable to the underwriter from the amounts held in the Trust
Account solely in the event the Company completes its Business Combination. In the event that the Company does not close the Business
Combination, the underwriter has waived its right to receive the Deferred Discount. The underwriter is not entitled to any interest accrued
on the Deferred Discount.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 6 – PRIVATE PLACEMENT
Simultaneously with the closing
of the Initial Public Offering on February 11, 2021, the Sponsor purchased an aggregate of or 225,000 Private Units at a price of $10.00
per Private Unit, ($2,250,000 in the aggregate), from the Company in a private placement. The proceeds from the sale of the Private Units
were added to the net proceeds from the Initial Public Offering held in the Trust Account. The Private Units are identical to the Units
sold in the Initial Public Offering, except for the private warrants (“Private Warrants”), as described in Note 9. If the
Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be
used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Units and underlying
securities will be worthless.
NOTE 7 – RELATED PARTY TRANSACTIONS
Founder Shares
In May 2018, the Company
issued one ordinary share to the Sponsor for no consideration. On August 21, 2019, the Company cancelled the one share for no consideration
and the Sponsor purchased ordinary shares for an aggregate price of $25,000.
The founder shares
(for purposes hereof referred to as the “Founder Shares”).
The founders and our officers
and directors have agreed not to transfer, assign or sell any of the Founder Shares (except to certain permitted transferees) until, with
respect to 50% of the Founder Shares, the earlier of (i) six months after the date of the consummation of a Business Combination, or (ii)
the date on which the closing price of the Company’s ordinary shares equals or exceeds $ per share (as adjusted for stock splits,
stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after a Business
Combination, with respect to the remaining 50% of the Founder Shares, upon six months after the date of the consummation of a Business
Combination, or earlier, in each case, if, subsequent to a Business Combination, the Company consummates a subsequent liquidation, merger,
stock exchange or other similar transaction which results in all of the Company’s shareholders having the right to exchange their
ordinary shares for cash, securities or other property.
Advance from Related Party
As of March 31, 2021, and
December 31, 2020, the Sponsor had advanced the Company an aggregate of $0 and $26,750, respectively. The advances are non-interest bearing
and due on demand.
Promissory Note Payable
On June 10, 2019, as amended
on January 16, 2020, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to an
aggregate principal amount of $450,000 (the “Promissory Note”). The Promissory Note is non-interest bearing and payable on
the earlier of (i) December 31, 2021 or (ii) the consummation of the Initial Public Offering (see Note 4). The outstanding balance under
the Promissory Note was repaid at the closing of the Initial Public Offering on February 11, 2021. As of March 31, 2021 and December 31,
2020, the principal amount due and owing under the Promissory Note was $0 and $228,483 respectively.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Administrative Services Arrangement
An affiliate of the Sponsor
agreed, commencing on February 8, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation,
to make available to the Company certain general and administrative services, including office space, utilities and administrative services,
as the Company may require from time to time. The Company has agreed to pay the affiliate of the Sponsor $10,000 per month for these services.
Related Party Loans
In order to finance transaction
costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers
and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working
Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without
interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination
into additional Private Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company
may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account
would be used to repay the Working Capital Loans.
Related Party Extension Loans
As discussed in Note 1, the
Company may extend the period of time to consummate a Business Combination up to nine times, each by an additional month (for a total
of 21 months to complete a Business Combination). In order to extend the time available for the Company to consummate a Business Combination,
the Sponsor or its affiliates or designees must deposit into the Trust Account $153,333 (approximately $0.033 per Public Share), up to
an aggregate of $1,380,000, or $0.30 per Public Share, on or prior to the date of the applicable deadline, for each one month extension.
Any such payments would be made in the form of a loan. The terms of the promissory note to be issued in connection with any such loans
have not yet been negotiated. If the Company completes a Business Combination, the Company would repay such loaned amounts out of the
proceeds of the Trust Account released to the Company. If the Company does not complete a Business Combination, the Company will not repay
such loans. Furthermore, the letter agreement with the shareholders contains a provision pursuant to which the Sponsor has agreed to waive
its right to be repaid for such loans in the event that the Company does not complete a Business Combination. The Sponsor and its affiliates
or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business Combination.
NOTE 8 – SHAREHOLDER’S EQUITY (DEFICIT) (AS RESTATED)
Ordinary Shares — The
Company is authorized to issue 50,000,000 ordinary shares, with a par value of $0.001 per share. Holders of the ordinary shares are entitled
to one vote for each ordinary share. At March 31, 2021, there were 1,450,000 ordinary shares issued and outstanding, excluding 4,600,000
ordinary shares subject to possible redemption.
Rights — Each holder
of a right will receive one-tenth (1/10) of one ordinary share upon consummation of a Business Combination, even if the holder of such
right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange of the
rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation
of a Business Combination as the consideration related thereto has been included in the Unit purchase price paid for by investors in the
Initial Public Offering. If the Company enters into a definitive agreement for a Business Combination in which the Company will not be
the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the
holders of the ordinary shares will receive in the transaction on an as-converted into ordinary share basis and each holder of a right
will be required to affirmatively convert its rights in order to receive 1/10 share underlying each right (without paying additional consideration).
The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company).
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
If the Company is unable
to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders
of rights will not receive any of such funds with respect to their rights, nor will they receive any distribution from the Company's assets
held outside of the Trust Account with respect to such rights, and the rights will expire worthless. Further, there are no contractual
penalties for failure to deliver securities to the holders of the rights upon consummation of a Business Combination. Additionally, in
no event will the Company be required to net cash settle the rights. Accordingly, the rights may expire worthless.
Public Warrants — Each
public warrant entitles the holder thereof to purchase one-half (1/2) of one ordinary share at a price of $11.50 per full share, subject
to adjustment as described in this prospectus. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for
a whole number of shares. This means that only an even number of warrants may be exercised at any given time by a warrant holder.
No public warrants will be
exercisable for cash unless the Company has an effective and current registration statement covering the ordinary shares issuable upon
exercise of the warrants and a current prospectus relating to such ordinary shares. It is the Company’s current intention to have
an effective and current registration statement covering the ordinary shares issuable upon exercise of the warrants and a current prospectus
relating to such ordinary shares in effect promptly following consummation of an initial business combination.
Notwithstanding the foregoing,
if a registration statement covering the ordinary shares issuable upon exercise of the public warrants is not effective within 90 days
following the consummation of our initial business combination, public warrant holders may, until such time as there is an effective registration
statement and during any period when we shall have failed to maintain an effective registration statement, exercise warrants on a cashless
basis pursuant to an available exemption from registration under the Securities Act. In such event, each holder would pay the exercise
price by surrendering the warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the
number of ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair
market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported
last sale price of the ordinary shares for the 10 trading days ending on the day prior to the date of exercise. For example, if a holder
held 300 warrants to purchase 150 shares and the fair market value on the date prior to exercise was $15.00, that holder would receive
35 shares without the payment of any additional cash consideration. If an exemption from registration is not available, holders will not
be able to exercise their warrants on a cashless basis.
The warrants will become
exercisable on the later of the completion of an initial business combination and March 31, 2022. The warrants will expire at 5:00 p.m.,
New York City time, on the fifth anniversary of our completion of an initial business combination, or earlier upon redemption.
The Company may redeem the
outstanding warrants (including any outstanding warrants issued upon exercise of the unit purchase option issued to Ladenburg Thalmann
& Co., Inc.,), in whole and not in part, at a price of $0.01 per warrant:
|
●
|
in whole and not in part,
|
|
●
|
at a price of $0.01 per warrant,
|
|
●
|
upon not less than 30 days' prior written notice of redemption
to each Public Warrant holder,
|
|
●
|
if, and only if, the reported last sale price of the ordinary
shares equal or exceed $18.00 per share, (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations,
recapitalizations and the like) for any 20 trading days within a 30 trading day period ending on the third trading day prior to the notice
of redemption to Public Warrant holders, and if, and only if, there is a current registration statement in effect with respect to the
ordinary shares underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing
each day thereafter until the date of redemption.
|
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
If the foregoing conditions are satisfied
and the Company would issue a notice of redemption, each warrant holder can exercise his, her or its warrant prior to the scheduled redemption
date. However, the price of the ordinary shares may fall below the $18.00 trigger price as well as the $11.50 warrant exercise price per
full share after the redemption notice is issued and not limit our ability to complete the redemption.
The redemption criteria for
the warrants have been established at a price which is intended to provide warrant holders a reasonable premium to the initial exercise
price and provide a sufficient differential between the then-prevailing share
NOTE
9 – FAIR VALUE MEASUREMENTS (AS RESTATED)
The fair value of the Company’s
financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with
the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants
at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the
use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions
about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities
based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
|
Level 1:
|
Quoted prices in active markets for identical assets or liabilities.
An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency
and volume to provide pricing information on an ongoing basis.
|
|
Level 2:
|
Observable inputs other than Level 1 inputs. Examples of
Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities
in markets that are not active.
|
|
Level 3:
|
Unobservable inputs based on our assessment of the assumptions
that market participants would use in pricing the asset or liability.
|
The following table presents
information about the Company’s assets that are measured at fair value on a recurring basis at March 31, 2021 and indicates the
fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
The following table presents
information about the Company’s assets and liabilities that were measured at fair value on a recurring basis as of March 31, 2021,
and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.
Schedule of Company's assets that are measured at fair value on a recurring basis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quoted Prices In
|
|
|
Significant Other
|
|
|
Significant Other
|
|
|
|
March 31, 2021
|
|
|
Active Markets
|
|
|
Observable Inputs
|
|
|
Unobservable Inputs
|
|
Description
|
|
(Unaudited)
|
|
|
(Level 1)
|
|
|
(Level 2)
|
|
|
(Level 3)
|
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Treasury Securities held in Trust Account*
|
|
$
|
46,460,382
|
|
|
$
|
46,460,382
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant liabilities (as restated)
|
|
$
|
390,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
390,000
|
|
|
*
|
included in cash and investments held in trust account on
the Company’s balance sheet.
|
The private warrants are
accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the balance sheets.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
The Company established the
initial fair value for the private warrants at $380,000 on February 11, 2021, the date of the Company’s Initial Public Offering,
using a Black-Scholes model. The Company allocated the proceeds received from the sale of Private Units, first to the private warrants
based on their fair values as determined at initial measurement, with the remaining proceeds recorded as ordinary shares subject to possible
redemption, and ordinary shares based on their relative fair values recorded at the initial measurement date. The warrants were classified
as Level 3 at the initial measurement date due to the use of unobservable inputs.
The key inputs into the binomial
model and Black-Scholes model were as follows at their measurement dates:
Schedule of binomial model and Black-Scholes model
|
|
|
|
|
|
|
|
|
|
|
March 31,
2021
|
|
|
February 11,
2021
(Initial
measurement)
|
|
Input
|
|
|
|
|
|
|
|
|
Share price
|
|
$
|
10.00
|
|
|
$
|
10.00
|
|
Risk-free interest rate
|
|
|
0.92
|
%
|
|
|
0.46
|
%
|
Volatility
|
|
|
44
|
%
|
|
|
44
|
%
|
Exercise price
|
|
$
|
11.50
|
|
|
$
|
11.50
|
|
Warrant life
|
|
|
5 years
|
|
|
|
5 years
|
|
As of March 31, 2021, the
aggregate value of the Private Warrants was $0.39 million. The change in fair value from February 11, 2021 to March 31, 2021 was approximately
$10,000.
To the extent that valuation
is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment.
Because of the inherent uncertainty of valuation, those estimated values may be materially higher or lower than the values that would
have been used had a ready market for the investments existed. Accordingly, the degree of judgment exercised by the Company in determining
fair value is greatest for investments categorized in Level 3. Level 3 financial liabilities consist of the Private Warrant liability
for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation.
Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in
estimates or assumptions and recorded as appropriate.
NOTE 10 – COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
Management continues to evaluate
the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect
on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily
determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from
the outcome of this uncertainty.
VENUS ACQUISITION CORPORATION
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
Registration Rights
The holders of the Founder
Shares, Private Units (and their underlying securities) and any Units that may be issued upon conversion of the Working Capital Loans
(and underlying securities) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to
or on the effective date of the Proposed Offering. The holders of these securities are entitled to make up to three demands, excluding
short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration
rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the
Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred
in connection with the filing of any such registration statements.
Leases
The Company entered into
short-term agreements for temporary office space expiring through October 31, 2021 and January 31, 2022. For the periods ended March 31,
2021 and 2020, the Company incurred rent expense of $11,247 and $0, respectively. The remaining amount due under these agreements for
the 12 months ending March 31, 2022 is $22,647.
Underwriting Agreement
The underwriters are entitled
to a deferred fee of 2.5% of the gross proceeds of the Initial Public Offering, or $1,150,000. The deferred fee will be paid in cash
upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms of the underwriting agreement.
NOTE 11 – SUBSEQUENT
EVENTS
In accordance with ASC Topic
855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur
after the balance sheet date but before this unaudited financial statements are issued, the Company has evaluated all events or transactions
that occurred after March 31, 2021, up through the date was the Company issued the unaudited condensed financial statements.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report
(the “Quarterly Report”) to “we,” “us” or the “Company” refer to Venus Acquisition Corporation.
References to our “management” or our “management team” refer to our officers and directors, references to the
“Sponsor” refer to Yolanda Management Corporation. The following discussion and analysis of the Company’s financial
condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere
in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements
that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes
“forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange
Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those
expected and projected. All statements, other than statements of historical fact included in this Form 10-Q/A including, without limitation,
statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding
the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking
statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,”
“seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking
statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently
available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and
results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s
registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s
securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable
securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result
of new information, future events or otherwise.
Overview
We were formed on May 14,
2018 formed under the laws of the Cayman Islands, as a blank check company for the purpose of engaging in a merger, share exchange, asset
acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more target businesses
or entities. Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region,
although we intend to focus on businesses that have a connection to the Asian market. We believe that we will add value to these businesses
primarily by providing them with access to the U.S. capital markets.
We presently have no revenue,
have had losses since inception from incurring formation costs and have had no operations other than the active solicitation of a target
business with which to complete a business combination. We have relied upon the sale of our securities and loans from our officers and
directors to fund our operations.
On February 11, 2021, the
Company consummated its initial public offering of 4,600,000 Units, which includes the full exercise of the over-allotment option. Each
Unit consists of one ordinary share, one redeemable warrant, and one right to receive one-tenth (1/10) of an ordinary share upon the consummation
of an initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $46,000,000.
Simultaneously with the closing of the initial business combination, the Company consummated a private placement (“Private Placement”)
of 225,000 units (the “Private Units”) at a price of $10.00 per Private Unit, generating total proceeds of $2,250,000. In
addition, the Company sold to Ladenburg Thalmann & Co., Inc., for $75, a total of 75,000 Shares.
A total of $46,460,000 of
the net proceeds from the IPO and the Private Placement were deposited in a trust account established for the benefit of the Company’s
public shareholders.
Transaction costs amounted
to $2,462,765, consisting of $805,000 of underwriting fees, $1,150,000 of deferred underwriting fees and $507,765 of other offering costs.
As a result of the IPO, the
Private Placement and sale of units to our underwriter, assuming the units were split into its component parts, we had: (i) 4,825,000
units, (ii) 6,050,000 ordinary shares, (iii) 4,825,000 rights to acquire an aggregate of 482,500 ordinary shares: and (iv) 4,825,000 warrants
to acquire 2,412,500 ordinary shares issued and outstanding as of February 11, 2021. We have not issued any securities since such date.
Our management has broad
discretion with respect to the specific application of the net proceeds of the initial business combination and the Private Placement,
although substantially all of the net proceeds are intended to be applied generally towards consummating a business combination.
Results of Operations
Our entire activity from
inception up to February 11, 2021 was in preparation for the initial public offering. Since the initial public offering, our activity
has been limited to the evaluation of business combination candidates, and we will not be generating any operating revenues until the
closing and completion of our initial business combination. We expect to incur increased expenses as a result of being a public company
(for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses. We expect our expenses to
increase substantially after this period.
For the quarter ended March
31, 2021, we had a net loss of $88,323, which was comprised of general and administrative expenses, interest income and change in fair
value of warrant liabilities.
Liquidity and Capital Resources
As of March 31, 2021, we
had cash of $211,814. Until the consummation of the initial public offering, the Company’s only source of liquidity was an initial
purchase of ordinary shares by the Sponsor, monies loaned by the Sponsor under a certain unsecured promissory note and advances from the
Sponsor.
On February 11, 2021, we
consummated the initial public offering of 4,600,000 Units (which includes the full exercise of the underwriter’s over-allotment
option), at a price of $10.00 per Unit, generating gross proceeds of $46,000,000. Simultaneously with the closing of the initial public
offering, we consummated the sale of 225,000 Private Units, at a price of $10.00 per Unit, generating gross proceeds of $2,250,000.
Following the initial public
offering and the exercise of the over-allotment option, a total of $46,000,000 was placed in the Trust Account. We incurred $2,462,765,
consisting of $805,000 of underwriting fees, $1,150,000 of deferred underwriting fees and $507,765 of other offering costs.
We intend to use substantially
all of the net proceeds of the initial public offering, including the funds held in the Trust Account, to acquire a target business or
businesses and to pay our expenses relating thereto. To the extent that our capital stock is used in whole or in part as consideration
to effect our business combination, the remaining proceeds held in the Trust Account, as well as any other net proceeds not expended,
will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety
of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research
and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees which
we had incurred prior to the completion of our business combination if the funds available to us outside of the Trust Account were insufficient
to cover such expenses.
We intend to use the funds
held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target
businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners,
review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a business
combination.
We do not believe we will
need to raise additional funds in order to meet the expenditures required for operating our business. This belief is based on the fact
that while we may begin preliminary due diligence of a target business in connection with an indication of interest, we intend to undertake
in-depth due diligence, depending on the circumstances of the relevant prospective acquisition, only after we have negotiated and signed
a letter of intent or other preliminary agreement that addresses the terms of our initial business combination. However, if our estimate
of the costs of undertaking in-depth due diligence and negotiating our initial business combination is less than the actual amount necessary
to do so, or the amount of interest available to use from the trust account is minimal as a result of the current interest rate environment,
we may be required to raise additional capital, the amount, availability and cost of which is currently unascertainable. In this event,
we could seek such additional capital through loans or additional investments from members of our management team, but such members of
our management team are not under any obligation to advance funds to, or invest in, us. In the event that the business combination does
not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from
our Trust Account would be used for such repayment. Such loans would be evidenced by promissory notes. The notes would either be paid
upon consummation of our business combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may
be converted upon consummation of our business combination into additional Private Units at a price of $10.00 per unit. The terms of such
loans by our initial shareholders, officers and directors, if any, have not been determined and no written agreements exist with respect
to such loans.
Off-balance sheet financing arrangements
We have no obligations, assets
or liabilities which would be considered off-balance sheet arrangements as of March 31, 2021. We do not participate in transactions that
create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would
have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing
arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial
assets.
Contractual obligations
We do not have any long-term
debt, capital lease obligations, operating lease obligations or long-term liabilities other than an agreement to pay our Sponsor a monthly
fee of $10,000 for general and administrative services, including office space, utilities and administrative services to the Company.
We began incurring these fees on February 8, 2021 and will continue to incur these fees monthly until the earlier of the completion of
the business combination and the Company’s liquidation.
Critical Accounting Policies
The preparation of financial
statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“GAAP”)
requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent
assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could
materially differ from those estimates. The Company has not identified any significant accounting policies.
Warrants
The Company accounts for
warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms
and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”)
480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The
assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability
pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether
the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net
cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This
assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly
period end date while the warrants are outstanding.
For issued or modified warrants
that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time
of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to
be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the
estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.
Ordinary shares subject to possible redemption
The Company accounts for
its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption
(if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary
shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of
uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares
are classified as shareholders’ equity. As of March 31, 2021, 4,600,000 ordinary shares subject to possible redemption which are
subject to occurrence of uncertain future events and considered to be outside of the Company’s control are presented as temporary
equity, outside of the shareholders’ equity section of the Company’s unaudited condensed balance sheet.